Hertel, Austin T.
McMillen, Cynthia M.
Hoehl, Ryan M.
Barbeau, Dominique J.
McElroy, Anita K.
Hartman, Amy L.
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (T32 AI060525, T32 AI060525, R01 AI150792, R01 AI150792, R01 AI150792, R01 AI150792)
Article History
Received: 28 April 2025
Accepted: 14 July 2025
First Online: 25 July 2025
Competing interests
: A.K.M. receives support from UC Davis as part of their CEPI-funded efforts towards advancing DDVax as a human vaccine candidate. All other authors declare no financial or non-financial competing interests.